Response predictors to treatment with pegylated interferon in chronic hepatitis B.

Abstract

The clinical and epidemiological importance of chronic B hepatitis is currently unquestionable as a cause of end-stage liver disease and hepatocellular carcinoma. Recently, predictors of treatment response of this disease have been studied, both before and during the course of medication. Therapy stopping rules have been proposed, which may be useful in… (More)

Topics

2 Figures and Tables

Cite this paper

@article{Ferreira2010ResponsePT, title={Response predictors to treatment with pegylated interferon in chronic hepatitis B.}, author={Paulo R. Ferreira and Simone de Barros Tenore}, journal={The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases}, year={2010}, volume={14 5}, pages={519-25} }